A PHASE 1 STUDY TO EVALUATE THE BIOEQUIVALENCE OF ORAL TABLET AND ORALLY DISSOLVING TABLET FORMULATIONS OF RIMEGEPANT, A SMALL MOLECULE CGRP RECEPTOR ANTAGONIST

被引：0
|
作者：
Croop, R. [1 ]
Ivans, A. [1 ]
Stock, D. [1 ]
Hould, J. [1 ]
Morris, B. A. [1 ]
Stringfellow, J. [1 ]
Jensen, C. M. [1 ]
Moulin, J. -A. [2 ]
Larouche, R. [2 ]
Tanguay, M. [2 ]
Coric, V. [1 ]
Lipton, R. B. [3 ]
机构：
[1] Biohaven Pharmaceut, New Haven, CT USA
[2] Syneos Hlth, Quebec City, PQ, Canada
[3] Albert Einstein Coll Med, New York, NY USA
来源：
CEPHALALGIA | 2018年 / 38卷
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
MTIS2018-1
引用
收藏
页码：142 / 143
页数：2
相关论文
共 50 条
  • [41] A Phase 1 Study to Evaluate the Bioavailability and Food Effect of 2 Solid-Dispersion Formulations of the TRPV1 Antagonist ABT-102, Relative to the Oral Solution Formulation, in Healthy Human Volunteers
    Othman, Ahmed A.
    Cheskin, Howard
    Locke, Charles
    Nothaft, Wolfram
    Dutta, Sandeep
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2012, 1 (01): : 24 - 31
  • [42] A Phase 1 Clinical Trial to Evaluate Pharmacodynamic Interactions After Oral Coadministration of Alcohol and the Highly Selective Glucocorticoid Receptor Antagonist, PT150
    Verrico, Christopher
    Patel, Marguerite
    Xu, Ashley
    Risbrough, Victoria
    Baker, Dewleen
    Kosten, Thomas
    NEUROPSYCHOPHARMACOLOGY, 2019, 44 (SUPPL 1) : 189 - 190
  • [43] Phase I and pharmacokinetic study of LY293111, an orally available small molecule known to be an LTB4 receptor antagonist, 5-lipoxygenase inhibitor and peroxisome proliferator activated receptor-gamma agonist (PPAR gamma)
    Budman, DR
    Schwartz, GK
    Endres, S
    Welch, M
    O'Reilly, E
    Barile-Thiem, B
    Brail, LH
    de Alwis, DP
    Cleverly, A
    Weitzman, A
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S89 - S89
  • [44] Preclinical pharmacological Characterization of INF904, an oral small molecule antagonist to complement 5a receptor1 (C5aR1)
    Liu, Rui
    Xu, Zhongli
    Chen, Ophelia
    Burnett, Bruce P.
    Habe, Maria
    Guo, Renfeng
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 73 - 73
  • [45] A Phase 1, randomized, open-label crossover study to evaluate the safety and pharmacokinetics of 400 mg albaconazole administered to healthy participants as a tablet formulation versus a capsule formulation
    van Rossem, Koen
    Lowe, Jenny A.
    CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2013, 5 : 23 - 31
  • [46] A phase 1 study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of danuglipron (PF-06882961), an oral small-molecule glucagon-like peptide-1 receptor agonist, in Japanese adults with type 2 diabetes mellitus
    Ono, Ryosuke
    Furihata, Kenichi
    Ichikawa, Yoshihiko
    Nakazuru, Yoshiomi
    Bergman, Arthur
    Gorman, Donal N.
    Saxena, Aditi R.
    DIABETES OBESITY & METABOLISM, 2023, 25 (03): : 805 - 814
  • [47] A Phase I study to explore the activity and safety of SCH532706, a small molecule chemokine receptor-5 antagonist in HIV type-1-infected patients
    Pett, Sarah L.
    McCarthy, Michael C.
    Cooper, David A.
    MacRae, Karen
    Tendolkar, Amol
    Norris, Richard
    Strizki, Julie M.
    Williams, Kenneth M.
    Emery, Sean
    ANTIVIRAL THERAPY, 2009, 14 (01) : 111 - 115
  • [48] Safety and Efficacy of Oral Chemokine Receptor 1 Antagonist CCX354-C in a Phase 2 Rheumatoid Arthritis Study
    Tak, Paul P.
    Balanescu, Andra
    Tseluyko, Vira
    Bojin, Silvia
    Drescher, Edit
    Dairaghi, Dan
    Miao, Shichang
    Marchesin, Vittorio
    Jaen, Juan
    Bekker, Pirow
    Schall, Thomas J.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (12): : 4046 - 4046
  • [49] SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo
    Strizki, JM
    Xu, S
    Wagner, NE
    Wojcik, L
    Liu, J
    Hou, Y
    Endres, M
    Palani, A
    Shapiro, S
    Clader, JW
    Greenlee, WJ
    Tagat, JR
    McCombie, S
    Cox, K
    Fawzi, AB
    Chou, CC
    Pugliese-Sivo, C
    Davies, L
    Moreno, ME
    Ho, DD
    Trkola, A
    Stoddart, CA
    Moore, JP
    Reyes, GR
    Baroudy, BM
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (22) : 12718 - 12723
  • [50] A Single-dose, Randomized, Open-label, Two-period Crossover Bioequivalence Study Comparing a Fixed-Dose Pediatric Combination of Lamivudine and Stavudine Tablet for Oral Suspension with Individual Liquid Formulations in Healthy Adult Male Volunteers
    Monif, Tausif
    Reyar, Simrit
    Tiwari, Hari Krishan
    Tippabhotla, Sudhakar Koundinya
    Khuroo, Arshad
    Thudi, Nageshwar Rao
    Ahmed, Sarfaraz
    Raghuvanshi, Rajeev
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2009, 59 (02): : 104 - 108
12345